---
title: "Psyence Biomedical Ltd. (PBM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PBM.US.md"
symbol: "PBM.US"
name: "Psyence Biomedical Ltd."
industry: "Biotechnology"
datetime: "2026-05-20T16:07:27.658Z"
locales:
  - [en](https://longbridge.com/en/quote/PBM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PBM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PBM.US.md)
---

# Psyence Biomedical Ltd. (PBM.US)

## Company Overview

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company’s lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.psyencebiomed.com](https://www.psyencebiomed.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.01 | 183 | 6.63 | 1.97 | 1.77 |
| PB | 0.34 | 19 | 0.44 | 0.27 | 0.22 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/PBM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/PBM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/PBM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/PBM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**